Window mean survival time
From MaRDI portal
Cites work
Cited in
(5)- On assessing survival benefit of immunotherapy using long-term restricted mean survival time
- Nonparametric analysis of delayed treatment effects using single-crossing constraints
- Studentized permutation method for comparing two restricted mean survival times with small sample from randomized trials
- Designing superiority trials with window mean survival time as a primary endpoint
- Assessing delayed treatment benefits of immunotherapy using long-term average hazard: a novel test/estimation approach
This page was built for publication: Window mean survival time
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628242)